by JDC | Jun 30, 2020 | News
Speed isn’t the only thing that matters in the quest for a vaccine to end the Covid-19 pandemic, according to an article published in Bloomberg. They may not cross the finish line first, but dozens of companies and universities still see an opening for inoculations...
by JDC | Jun 28, 2020 | News
Immunotherapy for breast cancer is developing rapidly as new studies demonstrate improved outcomes in subsets of breast cancer. Breast cancer is one of the most commonly diagnosed cancer types among women globally. Globally, there were an estimated 2.1...
by JDC | Jun 25, 2020 | News
Like a scene out of “Invasion of the Body Snatchers,” a virus infects a host and converts it into a factory for making more copies of itself. Now researchers have shown that a large group of viruses, including the influenza viruses and other serious...
by JDC | Jun 23, 2020 | News
– Levels of an antibody found in recovered COVID-19 patients fell sharply in 2-3 months after infection for both symptomatic and asymptomatic patients, according to a Chinese study, raising questions about the length of any immunity against the novel...
by JDC | Jun 21, 2020 | News
Aspen was an early COVID-19 hot spot in Colorado, with a cluster of cases in March linked to tourists visiting for its world-famous skiing. Tests were in short supply, making it difficult to know how the virus was spreading, according to a recent article published in...
Recent Comments